Use of risk scores to identify lower and higher risk subsets among COMPASS‐eligible patients with chronic coronary syndromes. Insights from the CLARIFY registry

Author:

Darmon Arthur12ORCID,Ducrocq Gregory12ORCID,Jasilek Adam3,Feldman Laurent12,Sorbets Emmanuel145ORCID,Ferrari Roberto6,Ford Ian3,Tardif Jean‐Claude7,Tendera Michal8,Fox Kim M.9,Steg Philippe Gabriel1259ORCID

Affiliation:

1. Université de Paris, Assistance Publique–Hôpitaux de Paris Paris France

2. FACT, French Alliance for Cardiovascular Trials, Hôpital Bichat Paris France

3. Robertson Centre for Biostatistics University of Glasgow Glasgow UK

4. Assistance Publique ‐ Hôpitaux de Paris, Hôtel Dieu Centre de Diagnostic et de Thérapeutique Paris France

5. INSERM U‐1148, Laboratory for Vascular Translational Science Paris France

6. Department of Cardiology University Hospital of Ferrara and Maria Cecilia Hospital, GVM Care and Research Cotignola Italy

7. Montreal Heart Institute Université de Montréal Montreal Canada

8. Department of Cardiology and Structural Heart Disease Medical University of Silesia, School of Medicine in Katowice Katowice Poland

9. National Heart and Lung Institute, Royal Brompton Hospital Imperial College London UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3